Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issues (Q37826969)
Jump to navigation
Jump to search
scientific article published on 08 January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issues |
scientific article published on 08 January 2011 |
Statements
1 reference
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: implications for clinical practice and open issues (English)
1 reference
1 reference
C Gridelli
1 reference
F De Marinis
1 reference
M Di Maio
1 reference
D Cortinovis
1 reference
T Mok
1 reference
8 January 2011
1 reference
Identifiers
1 reference